Skip to main
BEAM
BEAM logo

Beam Therapeutics (BEAM) Market Capitalization Overview

Market Cap: $1.72B as of Jun 30, 2025

$1.72B
Past Month+$118.66M (7.45%)
As of Jun 30, 2025, Beam Therapeutics (BEAM) has a market capitalization of $1.72B. Over the past 30 days, its market cap has decreased by -18.36%, while in the last 12 months, it has decreased by -16.71%.

Market capitalization represents the total value of Beam Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Beam Therapeutics (BEAM) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Beam Therapeutics (BEAM) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Beam Therapeutics (BEAM) Market Cap History

DateMarket CapChange
Jun 2, 2025$1.63B-18.36%
May 1, 2025$1.99B+13.25%
Apr 1, 2025$1.77B-16.18%
Mar 3, 2025$2.11B-0.87%
Feb 3, 2025$2.12B+3.60%
Jan 2, 2025$2.05B-12.71%

Beam Therapeutics (BEAM) End of Year Market Cap History

DateMarket CapChange
2025$1.72B-16.71%
2024$2.06B-7.44%
2023$2.22B-19.50%
2022$2.76B-49.24%
2021$5.43B+17.17%
2020$4.64B

FAQs About Beam Therapeutics (BEAM) Market Cap

As of Jun 30, 2025, the market capitalization of Beam Therapeutics (BEAM) is $1.72B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Beam Therapeutics’s market capitalization has increased by 7.45%, changing from $1.60B to $1.72B as of Jun 30, 2025.

In the last 3 months, Beam Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Beam Therapeutics’s market capitalization decreased from $2.22B in January to $2.06B in December, reflecting a -7.44% change.

In the past five years, Beam Therapeutics (BEAM) has had a compound annual growth rate (CAGR) of -15.02% in market capitalization. This means its market cap has shrunk at an average rate of -15.02% per year.

Beam Therapeutics (BEAM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.